1-5 of 5
K. Robinson
Close
Sort by
Journal Articles

Efficacy and Safety Profile of Long Term Exposure to Lenalidomide in Relapsed Multiple Myeloma.

Guillemette Fouquet, MD, Stéphanie Tardy, MD, Helene Demarquette, MD, Sarah Bonnet, MD, Julie Gay, MD, Houria Debarri, MD, Charles Herbaux, MD, Jessica Michel, MD, Aurore Perrot, MD, Caroline Serrier, MD, Suzanne K. Robinson, PhD, Darko Miljkovic, Pascale Morel, Catherine Boccacio, Herve AvetLoiseau, MD, Thierry Facon, MD, Cyrille Hulin, MD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2964.
https://doi.org/10.1182/blood.V120.21.2964.2964
Published: 2012
Journal Articles

Experience with Long-Term Lenalidomide (LEN) Treatment in the Clinical Setting: Results From the UK Revlimid ® Treatment Continuation Scheme™ (TCS)

Cathy D. Williams, MBBS, MCRP, FRCPath, Mathew Simcock, MSc, Imran Lodhi, MBBS, Suzanne K. Robinson, PhD, Faith E. Davies, MD
Journal: Blood
Blood (2012) 120 (21): 4067.
https://doi.org/10.1182/blood.V120.21.4067.4067
Published: 2012
Journal Articles

Lymphoma in Pregnancy: Excellent Fetal Outcomes and Maternal Survival in a Large Multicenter Analysis

Andrew M. Evens, DO, MSc, Ranjana Advani, MD, Izidore S Lossos, MD, Oliver W. Press, MD, PhD, Julie M Vose, MD, Francisco J. Hernandez-Ilizaliturri, MD, Barrett K Robinson, MD, MPH, Stevie Otis, MD, Liat Nadav Dagan, MD, PhD, Ramsey Abdallah, CRC, Aimee Kroll, MS, Jose Sandoval, MD, Jessica L Yarber, MD, Kelley V. Foyil, MS, Linda M Parker, Leo I. Gordon, MD, FACP, John P. Leonard, MD, Thomas M. Habermann, MD, Nancy L. Bartlett, MD
Journal: Blood
Blood (2011) 118 (21): 94.
https://doi.org/10.1182/blood.V118.21.94.94
Published: 2011
Journal Articles

Long Term Follow-Up of a Randomized Trial Comparing Response Adapted (RA), Non-Cross Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).

Richard H. Van der Jagt, K. Robinson, D.P. Sheridan, R. Delage, L.M. Larratt, L. Yetisir, G. Wells
Journal: Blood
Blood (2006) 108 (11): 1998.
https://doi.org/10.1182/blood.V108.11.1998.1998
Published: 2006
Journal Articles

The Leech Product Saratin Is a Potent Inhibitor of Both VWF and Integrin α 2 β 1 Binding to Collagen.

Tara C. White, BS, David K. Robinson, Hang Yin, Ph.D., William F. DeGrado, Ph.D., Stephen R. Hanson, Ph.D., Owen J.T. McCarty, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 3928.
https://doi.org/10.1182/blood.V108.11.3928.3928
Published: 2006